top of page

News & Views

Generis attracts more top talent

Creator of data and content management platform, CARA™, Generis ( appoints Bart Vervoort as Head of Sales to spearhead a new wave of CARA growth across Europe.

Based in Maastricht in the Netherlands, Bert will have particular focus on sectors including Manufacturing & Automotive to Financial Services & Government, as well as additional Life Sciences growth in Benelux & the Nordics.

“The scope for entire enterprises to transform themselves digitally is immense, and the urgency to do this has been intensified by the pandemic.  “Now, everyone needs the tools to work productively from anywhere – securely and in full compliance.  Generis can only benefit from this trend.  CARA for Life Science has already seen impressive growth, but there are numerous sectors outside of pharma that promise to be a major source of sales activity now.  The Generis mantra – of basing multiple applications and use cases on the same cloud-based platform and data/content lake – resonates widely,” says Vervoort.

“I’ve been dealing with companies in regulated industries for a long time now and have come to the same conclusions as Generis – that the future of content management will be data driven.  Whether a company is in life sciences, the automotive industry, or any other validated market, the data challenges are the same – not just to adhere to regulations, but also to be faster, more dynamic and more efficient, empowered by seamlessly-connected digital solutions rather than islands of separately-maintained silos.  This is where my interest lies, and where Generis stands out.”

Commenting on the company’s latest major talent coup, James Kelleher, CEO and founder of Generis, says “We’re beyond thrilled to welcome Bart to our senior EMEA business development team.  His experience and mind-set couldn’t be better suited to Generis, and together we’re excited to see what the next year has in store.”

Bart’s appointment comes hot on the heels of the announcement of Mark Willoughby, Generis’s new Head of Life Sciences, last month (

bottom of page